142 related articles for article (PubMed ID: 155698)
1. Binding phenomena of isolated unique plasmic degradation products of human cross-linked fibrin.
Olexa SA; Budzynski AZ
J Biol Chem; 1979 Jun; 254(11):4925-32. PubMed ID: 155698
[TBL] [Abstract][Full Text] [Related]
2. Primary soluble plasmic degradation product of human cross-linked fibrin. Isolation and stoichiometry of the (DD)E complex.
Olexa SA; Budzynski AZ
Biochemistry; 1979 Mar; 18(6):991-5. PubMed ID: 154923
[TBL] [Abstract][Full Text] [Related]
3. Effects of fibrinopeptide cleavage on the plasmic degradation pathways of human cross-linked fibrin.
Olexa SA; Budzynski AZ
Biochemistry; 1980 Feb; 19(4):647-51. PubMed ID: 6444516
[TBL] [Abstract][Full Text] [Related]
4. Interaction between complementary polymerization sites in the structural D and E domains of human fibrin.
Ugarova TP; Budzynski AZ
J Biol Chem; 1992 Jul; 267(19):13687-93. PubMed ID: 1618867
[TBL] [Abstract][Full Text] [Related]
5. A re-examination of the cleavage of fibrinogen and fibrin by plasmin.
Ferguson EW; Fretto LJ; McKee PA
J Biol Chem; 1975 Sep; 250(18):7210-8. PubMed ID: 126232
[TBL] [Abstract][Full Text] [Related]
6. Complex-formation between the fibrin-derived plasmic fragments DD and E demonstrated by crossed immunoelectrophoresis.
Gogstad GO; Brosstad F
Thromb Res; 1983 Jun; 30(5):441-8. PubMed ID: 6225217
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the physicochemical properties of fragment D derivatives of fibrinogen and fragment D-D of cross-linked fibrin.
Marder VJ; Budzynski AZ; Barlow GH
Biochim Biophys Acta; 1976 Mar; 427(1):1-14. PubMed ID: 130927
[TBL] [Abstract][Full Text] [Related]
8. Structure of fragment E species from human cross-linked fibrin.
Olexa SA; Budzynski AZ; Doolittle RF; Cottrell BA; Greene TC
Biochemistry; 1981 Oct; 20(21):6139-45. PubMed ID: 6458323
[TBL] [Abstract][Full Text] [Related]
9. Modification of high molecular weight plasmic degradation products of human crosslinked fibrin.
Olexa SA; Budzynski AZ; Marder VJ
Biochim Biophys Acta; 1979 Jan; 576(1):39-50. PubMed ID: 153766
[TBL] [Abstract][Full Text] [Related]
10. Degradation of fibrinogen and fibrin by plasmin and nonplasmin proteases in the chronic subdural hematoma: evaluation by sodium dodecyl sulfate-polyacrylamide gel electrophoresis and immunoblot.
Nomura S; Kashiwagi S; Ito H; Mimura Y; Nakamura K
Electrophoresis; 1993 Dec; 14(12):1318-21. PubMed ID: 8137796
[TBL] [Abstract][Full Text] [Related]
11. Expression of primary polymerization sites in the D domain of human fibrinogen depends on intact conformation.
Cierniewski CS; Kloczewiak M; Budzynski AZ
J Biol Chem; 1986 Jul; 261(20):9116-21. PubMed ID: 3722190
[TBL] [Abstract][Full Text] [Related]
12. Interaction of fibrinogen and its derivatives with fibrin.
Husain SS; Weisel JW; Budzynski AZ
J Biol Chem; 1989 Jul; 264(19):11414-20. PubMed ID: 2738072
[TBL] [Abstract][Full Text] [Related]
13. Calcium modulates plasmin cleavage of the fibrinogen D fragment gamma chain N-terminus: mapping of monoclonal antibody J88B to a plasmin sensitive domain of the gamma chain.
Odrljin TM; Rybarczyk BJ; Francis CW; Lawrence SO; Hamaguchi M; Simpson-Haidaris PJ
Biochim Biophys Acta; 1996 Nov; 1298(1):69-77. PubMed ID: 8948490
[TBL] [Abstract][Full Text] [Related]
14. Characterization of fragment E from fibrinogen and cross-linked fibrin.
Slade CL; Pizzo SV; Taylor LM; Steinman HM; McKee PA
J Biol Chem; 1976 Mar; 251(6):1591-6. PubMed ID: 815259
[TBL] [Abstract][Full Text] [Related]
15. Plasmic degradation of crosslinked fibrin. Characterization of new macromolecular soluble complexes and a model of their structure.
Francis CW; Marder VJ; Barlow GH
J Clin Invest; 1980 Nov; 66(5):1033-43. PubMed ID: 6448866
[TBL] [Abstract][Full Text] [Related]
16. [Analysis of cross-linked fibrin and fibrinogen degradation products with SDS-PAGE and immunoblot].
Okumura N; Kagiya H; Kumagai T; Kameko M; Tozuka M; Saito H; Katsuyama T; Kanai M
Rinsho Byori; 1990 Feb; 38(2):201-7. PubMed ID: 2329722
[TBL] [Abstract][Full Text] [Related]
17. Progressive exposure of E-neoantigen associated with degradation of crosslinked fibrin by plasmin in vitro.
Stegnar M; Chen JP
Thromb Haemost; 1984 Dec; 52(3):315-20. PubMed ID: 6241755
[TBL] [Abstract][Full Text] [Related]
18. Binding of fibrin fragments to one-chain and two-chain tissue-type plasminogen activator.
Hasan AA; Chang WS; Budzynski AZ
Blood; 1992 May; 79(9):2313-21. PubMed ID: 1571544
[TBL] [Abstract][Full Text] [Related]
19. Degradation of cross-linked fibrin by human leukocyte proteases.
Francis CW; Marder VJ
J Lab Clin Med; 1986 Apr; 107(4):342-52. PubMed ID: 3514776
[TBL] [Abstract][Full Text] [Related]
20. Characterization of peptides cleaved by plasmin from the C-terminal polymerization domain of human fibrinogen.
Southan C; Thompson E; Panico M; Etienne T; Morris HR; Lane DA
J Biol Chem; 1985 Oct; 260(24):13095-101. PubMed ID: 2932434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
